Connect with us


Achiko establishes a joint venture with PT Indonesia Farma Medis for the production and distribution of its test platform for Covid-19 in Indonesia


  • Achiko signs agreement with PT Indonesia Farma Medis to establish a new joint venture, including a contract with PT Mitra Asa Pratama and a memorandum of understanding with PT Pharos Indonesia, completion subject to formal approvals
  • Test kits will be integrated with Achiko’s Teman Sehat (Health Buddy) mobile app to address growing demand for Covid-19 testing in Indonesia
  • The joint venture and the contracts are a precursor to product registration, currently planned to be filed in the next few weeks

ZURICH, SWITZERLAND – EQS Newswire – 12 February 2021 – Achiko AG (SWX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) and PT Indonesia Farma Medis (“PIFM”) have signed an agreement to establish the joint venture company PT Achiko Medika Indonesia (“PAMI”) for the production, distribution and marketing of its testing platform developed from Project Gumnuts for Indonesia.

Khairudin Gustam, Chief Executive Officer of PIFM said: “As Covid-19 cases across Indonesia have surged past the one million mark and the contagiousness of the disease continues to severely disrupt the economy, the need for mass market testing becomes apparent. The economy needs to find a way to function, but given the size and population of Indonesia, reliance on PCR testing is not enough. Additional testing methods for Covid-19 are needed and we believe the Project Gumnuts technology is a key solution to help the country and the economy get back on their feet.”

Indonesia is a country of over 270 million people spread across several thousand islands. It is currently recording the highest number of cases, rates of positivity and fatality rates in Southeast Asia.

Phase 1 testing for Project Gumnuts has been concluded recently, achieving preliminary values of 91% sensitivity and 85% specificity. Further optimisation studies are currently being conducted in Spain and Indonesia to meet the World Health Organisations’ (WHO) standards.

“We are proud to be involved with Achiko’s development and look forward to the availability of Gumnuts for Indonesians, as most low cost rapid tests are too expensive for daily testing. The price point and convenience that Gumnuts can offer will enable tens of millions of people the ability to test almost daily. This will be a powerful tool in stopping the spread and beating Covid-19 and other pathogens,” said the Mayor of Pekanbaru in Indonesia, Dr. H. Firdaus S.T., M.T.

Achiko holds 50% of the PT Achiko Medika Indonesia joint venture registered today. PIFM and Achiko will jointly manufacture and assemble Project Gumnuts test kits for the Indonesian market, with PIFM tasked with the distribution and marketing, and Achiko earning a 10% licensing fee from gross sales. As new tests are developed, they will be similarly assembled and sold in the country.

Part of the joint venture is a contract with PT Mitra Asa Pratama (“Mitra”) and a memorandum of understanding with PT Pharos Indonesia (“Pharos”), along with several other companies, which are all subject to regulatory approval. Mitra is a leading distributor of medical and diagnostic devices in Indonesia, with vast network reach into government, healthcare institutions and retail markets, and will help with further distribution and marketing. Pharos is one of Indonesia’s largest pharmaceutical conglomerates with reach into two of the biggest pharmacy groups in the country, developing and marketing innovative products in Indonesia and other countries in Southeast Asia, with manufacturing facilities in Indonesia, Singapore and Vietnam.


They will be responsible for assembly, distribution and marketing. The Company has also started to engage in several other commercial arrangements in Indonesia.

“We are excited to be part of the fight against Covid-19 and all its successors and look forward to working with Achiko and PIFM to get this platform to market in the first half of 2021 as soon as the approval from the Ministry of Health is secured,” said Ida Nurtika, Director of Corporate Communication at PT Pharos Indonesia.

“The need for an effective and efficient diagnostic tool is increasing dramatically. We are proud to be able to use our expertise in healthcare distribution to help Achiko’s team deliver on this very important initiative, to collectively help the people of Indonesia manage this pandemic,” said Mitra’s Chief Executive Officer, Victory Theodorus.

“This joint venture is a major milestone for Achiko and a precursor to an imminent filing for product registrations and approvals in Indonesia,” said Steven Goh, Chief Executive Officer of Achiko. “Through PT Achiko Medika Indonesia, we have some of the best possible partners we can have to make a testing platform based on Projects Gumnuts, first with version 1.5 of our product and then many more to come. With comprehensive low-cost rapid and near universal testing, we can help Indonesia beat the Covid-19 pandemic.”

Next steps see the completion of regulatory approvals, getting the technology into test kits and moving them into the market as soon as practicable.

The issuer is solely responsible for the content of this announcement.

About Achiko AG

We harness ground-breaking science with innovative technology to create solutions that provide a great user experience for patients, physicians and governing bodies alike, leading ultimately to the transformation of the healthcare industry.

The current development of our patent pending diagnostic testing for Covid-19 (Project Gumnuts) provides an easy and effective way that enables people to obtain the information they need and require. Complemented by our mobile check-in app (Teman Sehat), we empower users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences, obtain passport verification and find community.

Achiko holds exclusive commercialisation rights to the technology underlying Project Gumnuts from It may be used to detect all types of Covid-19, but also many other pathogens. Achiko is looking forward to the completion of regulatory approval and getting the technology to market as quickly as possible, applying it in an array of test kits and other assay formats.

Headquartered in Zurich, we have offices in Hong Kong, Jakarta, Singapore and Seoul.

About PT Indonesia Farma Medis

PT Indonesia Farma Medis (“PIFM”) is a medical device and pharmaceutical distribution company with a large network of relationships and distribution channels that includes hospitals, pharmacies and clinics across the main islands of Indonesia.

PIFM provides supply chain solutions for distributing medical products and helps companies seeking market entry navigate the complexities of the Indonesian market.

About PT Mitra Asa Pratama
Mitra Asa Pratama collaborates with various international medical device brands to bring innovations to market and has been improving the overall healthcare technology in Indonesia for more than 20 years. With an extensive distribution network built by working closely with our sub-distributor partners, we cover hospitals, clinics, public health centers and offices, medical professionals, as well as the retail market.

It has been a long-standing part of our strategic vision to be able to build a vertically integrated company, where every business unit shares the same dedication to customer service. We firmly believe that service levels must always exceed expectations so that our clients, the medical professionals, can concentrate on the very important business of caring for patients.

About PT Pharos Indonesia
PT Pharos Indonesia is a major regional pharmaceutical company that develops and markets innovative products in Indonesia and other countries in South-East Asia.

The company was established on 30 September 1971 by Dr. Eddie Lembong, a visionary entrepreneur who wanted to build a modern, efficient, high quality, Indonesian pharmaceutical company. Dr. Lembong’s plan was realized early and today Pharos remains one of Indonesia’s leading pharmaceutical companies.

On June 30, 1990 Pharos became the first Indonesian company to receive a certification of the local version of GMP (CPOB), confirming Pharos’ ‘no compromises’ manufacturing standards.

Currently, Pharos and its subsidiaries employ more than 5,000 talents across Indonesia.


WiMi Wins Bid for Second Phase of China Mobile AND Media Cloud Platform's Remote Interaction Holographic Project


BEIJING, Feb. 19, 2021 /PRNewswire/ — WiMi Hologram Cloud Inc. (Nasdaq: WIMI) (“WiMi” or the “Company”), a leading Hologram Augmented Reality (“AR”) Technology provider in China, today announced that it has won the bid for the second phase of China Mobile AND Media Cloud Platform's remote interaction holographic project (the “Project”).

Bidding for the Project started at 10 AM Beijing time on February 1, 2021. All companies in China's holographic and communication industries were able to fill out an application. The application evaluation process was executed according to the bid evaluation method specified in the Bidding Laws of the People's Republic of China, other related regulations, and bidding documents. After a series of rigorous evaluations, it was decided that WiMi's application stood out from the rest, and according to the bidding result announcement released on February 10, 2021 at China Mobile's official website, WiMi won the bid.

With hundreds of millions of users, China Mobile is the largest mobile communication operator and leading operator of 5G mobile communication infrastructure in China. As of December 2020, China Mobile had 165 million customers with 5G data plan and 775 million customers with 4G data plan. With its comprehensive communication infrastructure and superior high-bandwidth 5G mobile communication network, China Mobile maintains broad development prospects in the field of remote interaction holographic communication. WiMi's status as a qualified supplier and partner for China Mobile marks a significant improvement in the Company's overall competitiveness. Going forward, as domestic communication operators continue to increase their investment into 5G technologies each year, it is expected that WiMi will also achieve significant advances and strategic breakthroughs in terms of its collaborations with 5G operators in China.

The selection of WiMi for the Project is further evidence of the Company's strong technical strengths. As a leading AR hologram technology provider for holographic 5G communication applications, the Company remains committed to independent R&D as well as investment into 5G and other core technology fields. Going forward, the Company plans to utilize such advanced technologies as 5G, AR, virtual reality, holographic communications, and more, to continue strengthening its collaborations with China Mobile as well as other communication operators and industry partners. At the same time, the Company will also focus on leveraging these technologies to further promote the development of its holographic 5G communication business while further accelerating the digital transformation of domestic holographic communication applications in other industry verticals.

About WIMI Hologram Cloud Inc.

WiMi Hologram Cloud, Inc.(NASDAQ: WIMI), whose commercial operations began in 2015, is a holographic cloud comprehensive technical solution provider that focuses on professional areas including holographic AR automotive HUD software, holographic pulse laser, head-mounted light field holographic equipment, holographic semiconductor, holographic cloud software, holographic car navigation and others. Its services and holographic AR technologies include holographic AR automotive application, holographic laser automotive application, holographic vision semiconductor technology, holographic software development, holographic AR advertising technology, holographic AR entertainment technology, holographic ARSDK payment, automobile holographic communication and other holographic AR technologies. For more information, please visit

Safe Harbor / Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Statements that are not historical facts, including statements about the Company's beliefs and expectations, are forward-looking statements. Among other things, the business outlook and quotations from management in this press release, as well as the Company's strategic and operational plans, contain forward−looking statements. The Company may also make written or oral forward−looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”) on Forms 20−F and 6−K, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward−looking statement, including but not limited to the following: the Company's goals and strategies; the Company's future business development, financial condition and results of operations; the expected growth of the AR holographic industry; and the Company's expectations regarding demand for and market acceptance of its products and services. Further information regarding these and other risks is included in the Company's annual report on Form 20-F and current report on Form 6-K and other documents filed with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable laws. 

WIMI Hologram Cloud Inc.
Email: [email protected]


Sharon Zhou
Tel: +1 (646) 975-9495
Email: [email protected]

Cision View original content:

SOURCE WiMi Hologram Cloud Inc.

Continue Reading


Texas Tech University Selects Heliospectra's Adjustable ELIXIA LED Lighting Solutions


GOTHENBURG, Sweden, Feb. 19, 2021 /PRNewswire/ — Heliospectra AB (publ) (Nasdaq First North Growth Market: HELIO, and North American ADR OTCQB: HLSPY), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from Texas Tech University of Lubbock, Texas, United States. The order is of Heliospectra's fully adjustable ELIXIA Led lighting solution and the order value is $ 287,250 USD

The lights will be installed in the Institute of Genomics for Crop Abiotic Stress Tolerance (IGCAST) Phytotron, located on the beautiful Texas Tech University campus in Lubbock. The Phytotron consists of both state-of-the-art growth chambers and enclosed greenhouses used for researching relationships between plants and the environment, to optimize crop production in terms of yield and quality under adverse environmental conditions. A flexible adjustable light source, such as Heliospectra's ELIXA, allow researchers to mimic environmental conditions and geographical areas from around the world. The Phytotron was built in 2019 as part of a larger effort to increase quality research capabilities in the State of Texas. 

Heliospectra's ELIXIA is designed and built on a foundation of over a decade of research and experience. ELIXIA, featuring up to four tunable wavelengths, is an essential tool for any commercial or research operation looking for full control and flexibility while seeking to deliver superior crop quality.

The order will be delivered in Q2, 2021. 

For More Information:

Rebecca Nordin, Head of IR at Heliospectra | +46 (0)72 536 8116 | [email protected]

This information was brought to you by Cision,c3290453

The following files are available for download:

Cision View original content:

SOURCE Heliospectra

Continue Reading


Fusion energy start-up HB11 Energy launched to accelerate German-Australian physicist Heinrich Hora's vision of clean, safe and abundant fusion energy

  • HB11 Energy raised $A 4.6M in an over-subscribed pre-seed financing round.
  • HB11 Energy has launched its experimental program developing a new source of clean, safe and reliable electricity using the fusion hydrogen and boron-11 (the HB11 reaction).
  • New on the board: German entrepreneur, investor and multiple founder Lukasz Gadowski.

SYDNEY, Feb. 19, 2021 /PRNewswire/ — HB11 Energy Holdings Pty Ltd recently closed its oversubscribed pre-seed fundraise at $A4.6M and commenced its experimental program after opening the round in April 2020.

Scientific Director Prof Heinrich Hora (left), and Managing Director Dr Warren McKenzie (right).

This investment has established Australia's first commercial fusion energy company, which will now drive an international R&D program aimed at the Holy Grail of fusion energy research – to demonstrate net energy gain and prove that HB11 Energy can develop a clean, safe and virtually unlimited source of large-scale electricity production.

The round was entirely funded by high-net-worth individuals.  

“Since launching our pre-seed round in April last year, we've been overwhelmed by investors interested in the environmental impact of our technology, as well as the financial returns inherent in our success,” said Dr Warren McKenzie, Founder and Managing Director of HB11 Energy.

Prof Hora's career's work has been motivated by the enormous benefits of the HB11 reaction for energy generation over other nuclear energy approaches. The HB11 reaction creates electricity directly, the fuels are safe and abundant, it does not create harmful radiation and there is no possibility of a reactor melt-down. Patents have been granted in four countries for Hora's concept generator.

“Our clean and absolutely safe reactor can be placed within densely populated areas, with no possibility of a catastrophic meltdown such as that which has been seen with nuclear fission reactors,” said Professor Heinrich Hora.

Prof Hora's theories, developed over half a century of research at UNSW Sydney, were validated in recent years with several academic research groups demonstrating the non-thermal initiation of the HB11 fusion reaction using high-peak-power lasers, of which two were published in 2020.  HB11 Energy has launched its experimental program with researchers from Australia, the USA and the UK.

Lukasz Gadowski appointed to the HB11 Energy Holdings Board

Gadowski is a deep-tech investor with a mission to deliver a better future via technology and a focus on clean energy and next-generation aviation. He has an impressive background as an entrepreneur having grown several companies to multi-billion-dollar valuations. Among these is Delivery Hero, which recently entered the DAX – Germany's leading stock market index. Others include Enpal, a German solar company for consumers, and Volocopter, globally leading company in the upcoming field of Urban Air Mobility.

“We are excited to welcome Lukasz Gadowski to the Board,” said Prof Hora. “His passion for physics, experience building many immensely successful multinational companies and perspective on the broad impact of our technology, all make Lukasz a most valuable addition to our team.”

“Professor Heinrich Hora is the pioneer of hydrogen-boron fusion technology – the most elegant approach that I have come across so far. Now we have to put theory into practice. A difficult task, but it's worth the effort alone,” Gadowski said. “It is an honour to be part of the revolution of energy production alongside Heinrich Hora.”

As HB11 Energy ramps up its R&D activities this year, it is taking expressions of interest for collaborations with university and public sector researchers. HB11 Energy is also planning to launch a seed fundraising round later this year and is interested in hearing from prospective investors.


Warren McKenzie (Australia / Asia)
[email protected]
Phone: +61-400-059-509

Jan Kirchhoff (Europe / US)
[email protected]  
Phone number: +352-691-274-42

Photo –

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Posts

gbafNews28 gbafNews28
News2 hours ago

SeABank AI Accelerates Digitization of Banking Ops

HANOI, Vietnam, Feb. 19, 2021 /PRNewswire/ — Viewing digitization as a pillar vital to support banking progression, Southeast Asia Commercial...

gbafNews28 gbafNews28
News2 hours ago

Latest ezAccounting Software Offers Businesses Greater Security As Stand Alone Application

TACOMOA, Wash., Feb. 19, 2021 /PRNewswire-PRWeb/ — Businesses can not afford to lose accounting and payroll data through security breaches. Small...

gbafNews28 gbafNews28
News2 hours ago

Fusion energy start-up HB11 Energy launched to accelerate German-Australian physicist Heinrich Hora's vision of clean, safe and abundant fusion energy

HB11 Energy raised $A 4.6M in an over-subscribed pre-seed financing round. HB11 Energy has launched its experimental program developing a...

gbafNews28 gbafNews28
News2 hours ago

Texas Tech University Selects Heliospectra's Adjustable ELIXIA LED Lighting Solutions

GOTHENBURG, Sweden, Feb. 19, 2021 /PRNewswire/ — Heliospectra AB (publ) (Nasdaq First North Growth Market: HELIO, and North American ADR...

gbafNews28 gbafNews28
News2 hours ago

WiMi Wins Bid for Second Phase of China Mobile AND Media Cloud Platform's Remote Interaction Holographic Project

BEIJING, Feb. 19, 2021 /PRNewswire/ — WiMi Hologram Cloud Inc. (Nasdaq: WIMI) (“WiMi” or the “Company”), a leading Hologram Augmented...

gbafNews28 gbafNews28
News2 hours ago

KAMPOS Expands into South Korea & Strengthens Its Sustainable Mission Internationally

PORTO CERVO, SARDINIA – Media OutReach – 10 February 2021 – KAMPOS, the ultimate Italian brand promoting luxury with integrity, is expanding overseas by...

gbafNews28 gbafNews28
News2 hours ago

GEODIS Charters Tonnage to Alleviate Container Capacity Shortage on Asia-Europe Trade

LEVALLOIS, PERRET – Media OutReach – 10 February 2021 – GEODIS, a leading global supply chain operator, provides its customers with guaranteed space in...

gbafNews28 gbafNews28
News2 hours ago

New Fujitsu LIFEBOOK takes New Workstyle Productivity to the Next Level

News facts: New line-up to enable the new normal includes high-performance business notebooks with 11th Gen Intel® CoreTM vProTM Processor...

gbafNews28 gbafNews28
News2 hours ago

A1 WORKMAN responds to the market of the home renovation trends

HONG KONG SAR – Media OutReach – 9 February 2021 – Although Covid-19 has brought depression to the world, it does not...

gbafNews28 gbafNews28
News2 hours ago

Fruitually keeps the supply of fruits to meet with the sales boom of the festive season

HONG KONG SAR – Media OutReach – 9 February 2021 – The Chinese New Year is approaching, and the sales boom of fruits has...